Abstract:Introduction The combination of inflammatory, benign and malignant processes in the prostate reduces the sensitivity, specificity and diagnostic accuracy of modern examination methods. The development of immunohistochemical methods (IHC) promotes the search for molecular markers that are diagnostically significant in various processes in the prostate. This will improve the detection of malignant neoplasms and reduce the number of "unnecessary" prostate biopsies. Objective to study in biopsies of patients with various prostate diseases the relationship of type 9 metalloproteinase (MMP-9) and its inhibitor (TIMP-1), the role of the Ki-67 protein proliferation level and the diagnostic value of the type IV collagen distribution indicator. Methods The study included 263 patients. They were divided into 4 groups: chronic prostatitis - 21 patients (mean age 65.2 ± 0.7 years), benign prostatic hyperplasia (BPH) - 65 patients (69.3 ± 1.1 years), BPH + prostatic intraepithelial neoplasia (PIN) - 59 patients (68.9 ± 0.9 years), prostate adenocarcinoma (PC) - 118 patients (68.2 ± 0.9 years). IHC was used to analyze type 9 metalloproteinase (MMP-9) and its inhibitor (TIMP-1), the role of the Ki-67 protein proliferation level and the diagnostic value of the type IV collagen distribution indicator. Results BPH is characterized by high production of MMP-9 (intensity 3 points), lack of proliferative activity of the secretory cell layer (Ki-67 less than 3.24 ± 0.61%) and degradation of collagen IV of the basement membranes, which associated with a compensatory increase in the activity of the inhibitor of matrix metalloproteinases TIMP-1 (intensity 3 points). In prostate cancer, as neoplastic changes increase, the production of the Ki-67 protein significantly increases, reflecting the proliferative activity of the secretory cell layer (from 5.3 + 1.1% to 17.2 + 9.4%). With an increase in the Gleason number over the 3rd grade, collagen fibers around the tumor cells completely disappear. The production of MMP-9 type in adenocarcinomas is significantly reduced and the destruction of collagen IV of the basement membrane of glandular structures and stroma occurs due to a progressive (up to an intensity of 0.8 + 0.4 points as anaplastic changes increase) decrease in the production of the inhibitor of matrix metalloproteinases TIMP-1 (p≤0.05). High production of MMR-9 in BPH is blocked by a high content of the TIMP-1 inhibitor. In adenocarcinomas, the production of MMP-9 is significantly reduced, but this protease destroys collagen IV of the basement membrane of glandular structures due to the absence or weak production of TIMP-1, which blocks the proteolytic effect of this enzyme on connective tissue collagen. The low production of the TIMP-1 inhibitor in adenocarcinomas can also explain the invasive properties of these tumors. Conclusions Comprehensive analysis of biomarkers in IHC can improve the diagnosis of prostate cancer and reduce the number of "unnecessary" biopsies. Disclosure No.

Detection of Type Ⅳ Collagen A2 and Integrin Β3 Expression in Prostate Cancer and Their Clinical Characteristics

Quantitative Detection of PCA3 mRNA and T1E4 mRNA-the Isoform of Fusion Gene TMPRSS2:ERG in Urine of Patients for the Early Clinical Diagnosis of Prostate Cancer

Applied Research of Prostate Specific Antigen Combined with Prostate Cancer Gene 3 in Diagnosis of Prostate Disease

Integrative analysis regarding the correlation between collagen-related genes and prostate cancer

[Correlation Between Integrin Subunits Alpha5 and Beta1 Expressions in Prostate Cancer and Its Clinical Implication].

Expression of TGF Β 1 and Β 3 in Prostate Cancer

A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach.

[Type IV Collagenase Expression in Human Prostate Carcinoma Cell Lines with Different Metastasis Potentials].

Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.

[Expressions of E-cadherin and Alpha-Catenin in Benign, Malignant and Metastatic Prostate Tumors].

Expression and immune infiltration studies of IL-33-ST2-NF-κB signaling pathway in prostate cancer

Study of Type Ⅲ Collagen α1 Polypeptide Chain Expression in Breast Cancer Tissues by Immunohistochemical Staining on Tissue Microarray

Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer

Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis

Expressions of signal transducer and activator of transcription 3 and nuclear factor of kappa B in prostate cancer and benign prostatic hyperplasia tissues

The Expression and the Significance of Survivin,p504s and P63 Proteins in Prostatic Pathologic Change

Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer

(248) Analysis of Biomarkers (MMP-9, TIMP-1, Ki-67 and Type IV Collagen) in the Diagnosis of Prostate Diseases

Detection and clinical significance of DD3 mRNA in the prostatic fluid of prostate cancer patients

CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.

IgG Gene Expression and Its Possible Significance in Prostate Cancers